Growing Infectious And Chronic Diseases And Increasing Point Of Care Centers Is Boosting The Global DNA Testing Market

According to a recently published report, the DNA Testing Market is expected to grow at the CAGR of 9.9% during 2015-2022. The segmentation of GLOBAL DNA TESTING MARKET is based on product type, technology, application, end userand geography. The report on GLOBAL DNA TESTINGMARKETForecast, 2015-2022 (byproduct type, technology, application, end userand geography) provides detailed overview and predictive analysis of the market.

Full report available GLOBAL DNA TESTING MARKETForecast, 2015-2022 (by application, product type and geography)report at http://www.briskinsights.com/report/dna-testing-market

Growing infectious and chronic diseases is the key driver to DNA testing market. The patient population is increasing rapidly due to growing infection caused by fungi, bacteria viruses;the need to detect the disease earlier DNA testing is being used. Increasing point of care center is another factor influencing the market largely. Point of care centers provides diagnosis and testing convenient to the patient residence and facilitates immediate results.

Scope of the report

1. GLOBAL DNA TESTING MARKET by product type, 2012 - 2022 ($ billion)
1.1. Instruments
1.2. Reagents
1.3. Software & Services

2. GLOBAL DNA TESTING MARKET by technology, 2012 - 2022 ($ billion)
2.1. PCR
2.2. Microarrays
2.3. In situ hybridization
2.4. Sequencing Technology
2.5. Mass Spectrometry

3. GLOBAL DNA TESTING MARKET by Application, 2012 - 2022 ($ billion)
3.1. Oncology
3.1.1. Prostate Cancer
3.1.2. Breast Cancer
3.1.3. Colorectal Cancer
3.2. Infectious disease testing
3.2.1. Hepatitis B Virus (HBV)
3.2.2. Hepatitis C Virus (HCV)
3.2.3. Human Immunodeficiency Virus (HIV)
3.2.4. Tuberculosis (TB)
3.2.5. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG
3.2.6. Human Papillomavirus (HPV)
3.2.7. Methicillin-Resistant Staphylococcus Aureus (MRSA)
3.3 Myogenic disorder diagnosis
3.4 Clinical diagnosis confirmation
3.5 Prenatal diagnosis
3.6 Pre-implantation diagnosis

4. GLOBAL DNA TESTING MARKET by end user, 2012 - 2022 ($ billion)
4.1. Point of Care
4.2. Central Laboratories/Diagnostic Centers
4.3. Self Testing/OTC

5. GLOBAL DNA TESTING MARKET by, regional outlook, 2012-2022(in $billion)
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Row

6. Company profiles
6.1. Novartis
6.2. Johnson and Johnson
6.3. Bio-Rad Laboratories
6.4. Thermo Fisher Scientific
6.5. Illumina, Inc.
6.6. Gen-probe Inc. (Hologic)
6.7. Cephide Inc.
6.8. Abbott Laboratories
6.9. Roche Diagnostics
6.10. Bayer Diagnostic
6.11. Sysmex
6.12. Agilent Technologies Inc.
6.13. GE Healthcare,
6.14. Transgenomic Inc
6.15. Qiagen